GE HealthCare Technologies Inc. (GEHC)
(Delayed Data from NSDQ)
$85.30 USD
+1.83 (2.19%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $85.26 -0.04 (-0.05%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
Balance Sheet
Fiscal Year End for GE HealthCare Technologies Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 2,504 | 1,445 | 556 | 1,007 | 0 |
Receivables | 3,557 | 3,312 | 3,259 | 2,054 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1,960 | 2,155 | 1,946 | 1,594 | 0 |
Other Current Assets | 1,389 | 1,406 | 1,239 | 1,241 | 0 |
Total Current Assets | 9,410 | 8,318 | 7,000 | 5,896 | 0 |
Net Property & Equipment | 2,500 | 2,314 | 1,877 | 1,797 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 4,474 | 1,550 | 1,287 | 1,489 | 0 |
Intangibles | 14,189 | 14,333 | 14,739 | 13,471 | 0 |
Deposits & Other Assets | 1,881 | 1,024 | 1,047 | 1,170 | 0 |
Total Assets | 32,454 | 27,539 | 26,308 | 24,228 | 0 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2,947 | 2,944 | 2,540 | 2,162 | 0 |
Current Portion Long-Term Debt | 1,006 | 15 | 6 | 4 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 5,028 | 4,232 | 4,215 | 4,358 | 0 |
Total Current Liabilities | 8,981 | 7,191 | 6,761 | 6,524 | 0 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 68 | 370 | 385 | 459 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 8,436 | 8,234 | 31 | 31 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 7,659 | 2,152 | 2,235 | 2,463 | 0 |
Minority Interest (Liabilities) | 165 | 230 | 220 | 0 | 0 |
Total Liabilities | 25,309 | 18,177 | 9,632 | 9,477 | 0 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 5 | 0 | 0 | 0 | 0 |
Capital Surplus | 6,493 | 0 | 0 | 0 | 0 |
Retained Earnings | 1,326 | 0 | 0 | 0 | 0 |
Other Equity | -679 | 9,362 | 16,676 | 14,751 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 7,145 | 9,362 | 16,676 | 14,751 | 0 |
Total Liabilities & Shareholder's Equity | 32,454 | 27,539 | 26,308 | 24,228 | 0 |
Total Common Equity | 7,145 | 9,362 | 16,676 | 14,751 | 0 |
Shares Outstanding | 455.36 | 454.71 | NA | NA | NA |
Book Value Per Share | 15.69 | 20.59 | -0.17 | -0.15 | 0.00 |
Fiscal Year End for GE HealthCare Technologies Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 2,015 | 2,563 | 2,504 | 2,418 | 1,939 |
Receivables | 3,354 | 3,344 | 3,557 | 3,400 | 3,397 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 2,023 | 1,989 | 1,960 | 2,128 | 2,264 |
Other Current Assets | 1,414 | 1,478 | 1,389 | 1,522 | 1,640 |
Total Current Assets | 8,806 | 9,374 | 9,410 | 9,468 | 9,240 |
Net Property & Equipment | 2,458 | 2,445 | 2,500 | 2,355 | 2,357 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 4,365 | 4,413 | 4,474 | 4,277 | 4,349 |
Intangibles | 14,311 | 14,101 | 14,189 | 14,246 | 14,352 |
Deposits & Other Assets | 1,913 | 1,878 | 1,881 | 2,036 | 2,013 |
Total Assets | 31,852 | 32,211 | 32,454 | 32,382 | 32,311 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2,824 | 2,931 | 2,947 | 2,774 | 2,835 |
Current Portion Long-Term Debt | 2,242 | 1,008 | 1,006 | 7 | 5 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 3,251 | 4,920 | 5,028 | 4,784 | 4,741 |
Total Current Liabilities | 8,318 | 8,859 | 8,981 | 7,565 | 7,581 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 55 | 68 | 68 | 62 | 81 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 8,233 | 8,247 | 8,436 | 10,253 | 10,233 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 7,251 | 7,659 | 7,199 | 7,093 | |
Minority Interest (Liabilities) | 177 | 177 | 165 | 161 | 209 |
Total Liabilities | 24,035 | 24,787 | 25,309 | 25,240 | 25,197 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 5 | 5 | 5 | 5 | 5 |
Capital Surplus | 6,540 | 6,504 | 6,493 | 6,469 | 6,451 |
Retained Earnings | 2,101 | 1,687 | 1,326 | 937 | 576 |
Other Equity | -829 | -773 | -679 | -269 | 82 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 7,817 | 7,423 | 7,145 | 7,142 | 7,114 |
Total Liabilities & Shareholder's Equity | 31,852 | 32,210 | 32,454 | 32,382 | 32,311 |
Total Common Equity | 7,817 | 7,423 | 7,145 | 7,142 | 7,114 |
Shares Outstanding | 456.66 | 456.47 | 455.30 | 455.20 | 454.80 |
Book Value Per Share | 17.12 | 16.26 | 15.69 | 15.69 | 15.64 |